Biopharmaceutical-related stocks showed mixed movements on the morning of the 7th, varying by individual stock. Samchundang Pharm rose more than 3% in a strong showing, while Bionex and HanAll Bio Pharma climbed. On the other hand, Hanmi Pharm, Aprogen, and Boryung declined.

■ Rising Stocks... Samchundang Pharm Leading with 3% Gains

As of this morning, Samchundang Pharm was trading at 161,900 won, up 3.12% from the previous trading day. It opened at 158,400 won, rose to as high as 162,200 won during the session, and recorded a low of 157,600 won.

Bionex was trading up 1.03% at 6,850 won, having risen to 6,920 won intraday. HanAll Bio Pharma was up 0.73% at 55,100 won, with the intraday high matching the current price.

Samsung Epis Holdings was trading 0.28% higher at 357,000 won. Chungkang Dang and ISU Abxis each rose 0.15%, while PanGen gained 0.10% and Daewoong Pharmaceutical added 0.09%.

■ Falling Stocks... Hanmi Pharm Down 2.22%

Hanmi Pharm was down 2.22% at 463,000 won. It opened at 475,000 won and rose to as high as 485,500 won intraday, but later slipped back into negative territory.

Aprogen fell 1.62% to 2,125 won, and Boryung declined 1.33% to 8,920 won. Dong-A ST also dropped 1.08% to 36,550 won.

Large-cap bio stocks were also relatively weak. Alteogen fell 0.52% to 287,000 won, and Celltrion declined 0.48% to 187,200 won. Green Cross was down 0.31%, and Celltrion Pharm fell 0.37%. Prestige Biologics and Prestige Biopharma were down 0.52% and 0.46%, respectively, while Aprogen Biologics slipped 0.17%.

■ Why Are the Stocks Moving in Different Directions?

Biopharmaceutical-related stocks cover a wide range of business areas, including new drug development, biosimilars, antibody drugs, contract development and manufacturing, and biopharmaceutical production. Even stocks within the same biopharmaceutical theme can move very differently depending on clinical trial progress, technology transfers, production facility utilization rates, product approvals, and orders.

Today's intraday movements also showed a differentiated market rather than the entire biopharmaceutical sector moving in one direction, with some stocks such as Samchundang Pharm and Bionex rising while Hanmi Pharm and Aprogen declined.

[※ This article was written to provide information on the domestic stock market and related stocks, and does not recommend the purchase or sale of specific stocks or guarantee investment returns. Stock prices can change rapidly depending on market conditions, and investment decisions and their consequences are the responsibility of the investor. This article was written with AI assistance.]